Yahoo India Web Search

Search results

  1. www.forbes.com › profile › nikil-viswanathan-1Nikil Viswanathan - Forbes

    Jun 30, 2024 · About Nikil Viswanathan. Nikil Viswanathan cofounded Alchemy, whose software powers thousands of blockchain-based Web3 companies. Alchemy, founded in 2020, was valued by private investors at...

  2. Jun 27, 2024 · Viswanathan Anand's success as India's first grandmaster ignited the country's chess boom. Now, D. Gukesh will follow in his footsteps as he faces world champion Ding Liren. The pandemic...

  3. Jul 1, 2024 · 1st July 2024, New Delhi. Dr. T.R. Sharma, Deputy Director General (Crop Science) ICAR, assumed additional charge as the Director of ICAR-IARI, today. He took over the charge from the Former Director, Dr. Ashok K. Singh. Dr. Sharma emphasized the importance of collaborative efforts in advancing agricultural research to meet the evolving ...

  4. Jun 24, 2024 · Viswanathan Anand, Indian chess master who won the world chess championship in 2000, 2007, 2008, 2010, and 2012. He was the first world chess champion from Asia. He was known for quick tactical calculations, which he displayed by winning numerous ‘speed chess’ titles.

    • The Editors of Encyclopaedia Britannica
  5. Jul 1, 2024 · Viswanathan Anand, the five-time world champion, showcased his exceptional skills once again by defeating Jaime Santos Latasa from Spain with a score of 3-1 in the finals, securing his 10th victory at the Leon Masters.

  6. 3 days ago · Business Summary. Ajanta Pharma Limited is an India-based specialty pharmaceutical company. The Company provides a comprehensive range of specialty branded generic products targeting a broad range of chronic and acute therapies.

  7. People also ask

  8. Jul 1, 2024 · Sharma takes over from the former Director, Dr. Ashok K. Singh. The handover ceremony was marked by the presence of members of the IARI leadership team, including Joint Director (Research) Dr. Chinnusamy Vishwanathan, Dean and Joint Director (Education) Dr. Anupama Singh, and Joint Director (Extension) Dr. R.N. Padaria.